Skip to content
10-K

Annual Report

GeoVax Labs, Inc. GOVX

0001437749-26-012377

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 15, 2026 2.89M sh
Capex FY 2025 · Dec 31, 2025 $27.61K
Capex FY 2025 · Dec 31, 2024 $20.65K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$21.47M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$24.68M
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.09M
Cash And Equivalents FY 2025 · Dec 31, 2024 $5.51M
Stockholders Equity FY 2025 · Dec 31, 2025 $3.83M
Stockholders Equity FY 2025 · Dec 31, 2024 $5.05M
Stockholders Equity FY 2025 · Dec 31, 2023 $5.76M
Current Liabilities FY 2025 · Dec 31, 2025 $1.94M
Current Liabilities FY 2025 · Dec 31, 2024 $3.11M
Total Liabilities FY 2025 · Dec 31, 2025 $2.52M
Total Liabilities FY 2025 · Dec 31, 2024 $3.11M
Current Assets FY 2025 · Dec 31, 2025 $5.31M
Current Assets FY 2025 · Dec 31, 2024 $7.93M
Total Assets FY 2025 · Dec 31, 2025 $6.34M
Total Assets FY 2025 · Dec 31, 2024 $8.16M
Eps Basic FY 2025 · Dec 31, 2025 −$22.40
Eps Basic restated FY 2025 · Dec 31, 2024 −$120.46
Sga Expense FY 2025 · Dec 31, 2025 $6.01M
Sga Expense FY 2025 · Dec 31, 2024 $5.39M
Rd Expense FY 2025 · Dec 31, 2025 $18.12M
Rd Expense FY 2025 · Dec 31, 2024 $23.71M
Net Income FY 2025 · Dec 31, 2025 −$21.46M
Net Income FY 2025 · Dec 31, 2024 −$24.99M
Operating Income FY 2025 · Dec 31, 2025 −$21.64M
Operating Income FY 2025 · Dec 31, 2024 −$25.14M
Revenue FY 2025 · Dec 31, 2025 $2.49M
Revenue FY 2025 · Dec 31, 2024 $3.95M